Elevated BFSP1 expression was significantly associated with several clinicopathological parameters, including primary tumor status, tumor stages I–III, tumor grades I–IV, histological subtype (particularly hepatocellular carcinoma), and TP53 mutation status. Here, BFSP1 is linked to hepatocellular carcinoma.